Pantoprazole from Actavis launched on patent expiry in Germany, Ireland, Netherlands

Actavis Group, the international generic pharmaceuticals company, launched Pantoprazole tablets in Germany, Ireland, and the Netherlands as the patent expired on 6 May. This is Actavis Group's first own brand launch of this molecule. In Germany and the Netherlands, the product was also launched by Actavis' third party sales division's (Medis') ... Read More...

Practical promotes corporate travel to Iceland by going to Germany

The popular corporate travel agency, Practical has announced its plan to attend IMEX – one of the world’s biggest exhibitions for incentive travel, meetings and events companies. IMEX will be held this May in Frankfurt. Practical is among Iceland’s biggest incentive travel, group travel, event management and teambuilding experts; and has ... Read More...

Was die Finanzkrise Privatanleger lehrt

Zweifellos sind wir weit davon entfernt, von einem Ende der Finanzkrise sprechen zu können. Entsprechend wissen wir auch nicht, wie sich die Kapitalmärkte und die Weltwirtschaft schlussendlich neu aufstellen werden. Trotzdem sollte der Privatanleger jenen Zuwachs an Erkenntnis, den ihm die Ereignisse der vergangenen Monate gebracht haben, für sein eigenes ... Read More...

Vodafone D2 Germany deploys cVidya’s Dealer Commission Verification Solution

Solution allows Vodafone to optimise dealers' commissioning process and prevent commission-settlement errors. London, UK, December 2, 2008 – cVidya Networks, a global leader of Telecom Data Integrity, Revenue Assurance and Dealer Management systems, announced today that Vodafone Germany has signed an agreement for implementation of cVidya's Data Integrity and DealerMap® ... Read More...

Actavis first to market generic prostate cancer drug Bicalutamide in the UK, Germany & France

Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the oncology drug to be made available in the three markets. Actavis has launched a generic drug for prostate cancer, Bicalutamide, in the UK, France and Germany. Bicalutamide, ... Read More...